Bank of America
RLAY icon

Bank of America’s Relay Therapeutics RLAY Stock Holding History

Bank of America’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4M Buy
2,695,108
+757,413
+39% +$11M ﹤0.01% 1691
2026
Q1 		$19.3M Buy
1,937,695
+896,746
+86% +$8.02M ﹤0.01% 2414
2025
Q4 		$8.81M Sell
1,040,949
-154,894
-13% -$1.11M ﹤0.01% 2950
2025
Q3 		$6.24M Sell
1,195,843
-124,287
-9% -$474K ﹤0.01% 3781
2025
Q2 		$4.57M Buy
1,320,130
+765,702
+138% +$2.28M ﹤0.01% 3993
2025
Q1 		$1.45M Buy
554,428
+97,134
+21% +$381K ﹤0.01% 4956
2024
Q4 		$1.88M Sell
457,294
-794,029
-63% -$4.32M ﹤0.01% 4495
2024
Q3 		$8.86M Buy
1,251,323
+455,841
+57% +$3.41M ﹤0.01% 3187
2024
Q2 		$5.19M Buy
795,482
+53,779
+7% +$367K ﹤0.01% 3583
2024
Q1 		$6.16M Buy
741,703
+429,513
+138% +$4.19M ﹤0.01% 3428
2023
Q4 		$3.44M Buy
312,190
+47,836
+18% +$404K ﹤0.01% 3881
2023
Q3 		$2.22M Sell
264,354
-114,402
-30% -$1.23M ﹤0.01% 4144
2023
Q2 		$4.76M Sell
378,756
-247,147
-39% -$3.07M ﹤0.01% 3455
2023
Q1 		$10.3M Buy
625,903
+271,414
+77% +$4.87M ﹤0.01% 2797
2022
Q4 		$5.3M Buy
354,489
+202,463
+133% +$3.88M ﹤0.01% 3338
2022
Q3 		$3.4M Buy
152,026
+30,665
+25% +$673K ﹤0.01% 3759
2022
Q2 		$2.03M Buy
121,361
+36,542
+43% +$783K ﹤0.01% 4289
2022
Q1 		$2.54M Sell
84,819
-68,325
-45% -$1.66M ﹤0.01% 4355
2021
Q4 		$4.7M Buy
153,144
+116,834
+322% +$3.69M ﹤0.01% 3716
2021
Q3 		$1.15M Sell
36,310
-24,986
-41% -$841K ﹤0.01% 4936
2021
Q2 		$2.24M Buy
61,296
+22,165
+57% +$730K ﹤0.01% 4224
2021
Q1 		$1.35M Buy
39,131
+30,692
+364% +$1.33M ﹤0.01% 4576
2020
Q4 		$350K Buy
8,439
+7,204
+583% +$326K ﹤0.01% 5244
2020
Q3 		$53K Buy
+1,235
New +$47.1K ﹤0.01% 5987

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Bank of America's RLAY Position: Q2 2026 in Review

Bank of America increased its Relay Therapeutics (RLAY) stake by 39% in Q2 2026, buying an estimated $11M and bringing the position to 2,695,108 shares worth $50.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Bank of America first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Bank of America held 2,695,108 shares of Relay Therapeutics worth $50.4M as of Q2 2026.
  • Bank of America bought 757,413 Relay Therapeutics shares in Q2 2026, an estimated $11M.
  • Relay Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1691 holding.
  • Bank of America first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.